CoMotion® at the University of Washington is the collaborative innovation hub dedicated to expanding the global economic and societal impact of the UW community.

CoMotion Success Stories

Success at CoMotion takes many forms – from successful UW spinoffs and startups, to acquisitions of UW projects or startups by leading companies, to licensing of UW IP to industry leaders for further development. UW has also been a frontrunner in “direct-to-user” licensing which provides finished products or services directly to end users. In addition, CoMotion offers numerous programs and fellowships in conjunction with its partners that offer funding, mentorship, connections, and opportunities to help bring ideas to life.

Recent UW spinoff milestones

C-SATS is acquired by Johnson & Johnson for an undisclosed amount, April

Universal Cells is acquired by Astellas ($102.5M in upfront and milestones), Feb

Neoleukin raises $82.6M on the public market, Dec

Lyell Immunopharma raises > $600M in series A, series B & partnerships, Dec

Cytocardia is acquired by Sana Biotechnology for an undisclosed amount, Nov

SonoMotion raises $10M in series B, Nov

Icosovax raises $51M in series A, Oct

A-Alpha Bio raises $2.8M in seed round, Sept

Neoleukin Therapeutics valued at $42.5M in stock swap with Aquinox, Aug

Novuson Surgical raises undisclosed amount from HOYA corporation, May

KenSci raises $22M in series B, Feb

Proprio raises $7M in seed funding, Jan

Membrion raises $6M in new funding, March

PvP Biologics is acquired by Takeda ($330M in payments and milestones), Feb

TwinStrand Biosciences raises $16M in series A, Jan